Pharmaceutical Product Development
|Industry||Contract research organizations
|Headquarters||Wilmington, North Carolina, United States|
|Key people||See Principal Officers page of the PPD Website |
|Products||Support services for pharmaceutical, biotechnology and medical device companies and academic and government organizations, including discovery, development and post-approval services as well as compound partnering programs.|
Pharmaceutical Product Development, LLC (PPD) is a global contract research organization (CRO) providing discovery, development and post-approval services as well as compound partnering programs. The company’s clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. PPD is mainly known for conducting drug development for its clients, it also invests in developing new products through its compound partnering program.
PPD was founded by Fred Eshelman, Pharm.D., as a one-person consulting firm in 1985. The following year he expanded the company's scope to include development services and relocated operations from Maryland to North Carolina.
PPD is headquartered in Wilmington, N.C. The company has approximately 12,500 employees in 46 countries.
PPD operates in two main segments: development services and discovery sciences/compound partnering. PPD has also forged strategic alliances with various biopharmaceutical companies and consulting firms in key areas of drug development.
PPD provides clinical development and post-approval services for biopharmaceuticals and medical devices. In addition to offering full service Phase II-IIIb clinical studies for multinational regulatory submissions, PPD provides bioanalytical, cGMP product analysis, global central laboratory, and vaccines and biologics lab services. PPD has a 300-bed healthy volunteer (Phase I) clinic and a dental research clinic in Austin, Texas.
The company’s post-approval services include epidemiology, risk management and outcomes research; late-stage trials; medical information; product safety; registries and observational studies.
PPD also offers clinical data management and information solutions, including consulting and proprietary software tools to speed collection, analysis and reporting of clinical data.
Discovery Sciences/Compound Partnering
The discovery sciences segment offers biomarker discovery services, nonclinical development and preclinical services. Through its compound partnering program, it also seeks to in-license early-stage compounds, take them through proof of concept, and out-license them to its partners for late clinical testing and commercialization. PPD shares in the risks and rewards of bringing a drug to market, gaining revenues generated by licensing fees, milestone payments and commercial royalties.